Trademarkia Logo

Australia

AU$
Trademark Search
BEYONTTRA

View On IPO.GOV.AU

BEYONTTRA
Protected: Registered/protected

Last updated on 14 Mar 2024

Owner Info

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250

Palo Alto CA 94304, UNITED STATES OF AMERICA

Serial Number

2302413 filed on 18 Aug 2022

Correspondent

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250,

Palo Alto CA 94304,

UNITED STATES OF AMERICA

BEYONTTRA

Classification Information

Class [005]
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and d Read More

Mark Details

Serial Number

2302413

Registered On

18 Aug 2022

Renewal On

18 Aug 2032

Mark Type

WORD

Priority Claim (Convention Details)

Date

28 Feb 2022

Mark Type

US

Legal History

Show more

Status DateAction Taken
14th Mar 2024Amendment to Amend Owner Requested
13th Dec 2022International Registration in Australia Protected correspondence sent
12th Dec 2022IP Right Registration Published
12th Dec 2022Status change to Registered/Protected
6th Oct 2022Application Accepted correspondence sent
5th Oct 2022IP Right has been Examined
5th Oct 2022IP Right Acceptance Published
5th Oct 2022Status change to Accepted
29th Sept 2022Examination expedited
29th Sept 2022Awaiting examination